• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单孔三维内镜辅助腋窝淋巴结清扫术(S-P 3D E-ALND):手术技术及初步结果

Single-Port Three-Dimensional Endoscopic-Assisted Axillary Lymph Node Dissection (S-P 3D E-ALND): Surgical Technique and Preliminary Results.

作者信息

Sae-Lim Chayanee, Lai Hung-Wen, Chennavasin Papawee, Huang Hsin-I, Lin Shih-Lung, Huang Ren-Hung, Chen Shou-Tung, Chen Dar-Ren

机构信息

Department of Surgery, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Endoscopic and Oncoplastic Breast Surgery Center, Changhua Christian Hospital, Changhua, Taiwan.

出版信息

Breast J. 2024 Dec 4;2024:6319218. doi: 10.1155/tbj/6319218. eCollection 2024.

DOI:10.1155/tbj/6319218
PMID:39742375
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11634405/
Abstract

Endoscopic-assisted breast surgery (EABS) provides better cosmetic outcomes for breast cancer patients with small incisions in an inconspicuous area. However, an extended incision and heavy assistant retraction are usually required for an adequate exposure for conventional axillary lymph node dissection (ALND). Therefore, we propose an innovative single-port three-dimensional endoscopic-assisted ALND (S-P 3D E-ALND) to facilitate better visualization, and report its preliminary outcomes herein. The surgical technique of the S-P 3D E-ALND, using either monopolar Endo Hook, LigaSure, or , is described. A total of 11 breast cancer patients who received the S-P 3D E-ALND in a single institution from January 2023 to September 2023 were enrolled. The preliminary results of the S-P 3D E-ALND, including perioperative parameters, complication, and short-term oncological outcomes, were retrospectively analyzed. Endoscopic breast and axillary procedures were conducted via a single axillary incision. The primary success rate of the S-P 3D E-ALND was 100% without a conversion to open surgery. The median operative time for the S-P 3D E-ALND was 39 (IQR = 28, 49) minutes. Average blood loss during E-ALND was 3 (IQR = 3, 5) mL. The median number of harvested LN was 10 (IQR = 8, 11) LNs. During the median follow-up time of 7 months, there was no complication, lymphedema, shoulder stiffness, or chronic arm numbness found. None of the patients reported locoregional recurrence, distant metastasis, or mortality. The S-P 3D E-ALND can serve as an alternative approach for ALND in breast cancer patients undergoing EABS, as our findings indicate it results in only minor complications.

摘要

内镜辅助乳腺手术(EABS)为乳腺癌患者提供了更好的美容效果,切口小且位于不显眼的区域。然而,传统腋窝淋巴结清扫术(ALND)为充分暴露通常需要延长切口并由助手大力牵拉。因此,我们提出一种创新的单孔三维内镜辅助ALND(S-P 3D E-ALND)以利于更好的可视化,并在此报告其初步结果。描述了使用单极内镜钩、LigaSure或其他器械的S-P 3D E-ALND的手术技术。纳入了2023年1月至2023年9月在单一机构接受S-P 3D E-ALND的11例乳腺癌患者。回顾性分析了S-P 3D E-ALND的初步结果,包括围手术期参数、并发症和短期肿瘤学结果。内镜下乳腺和腋窝手术通过单一腋窝切口进行。S-P 3D E-ALND的主要成功率为100%,无需转为开放手术。S-P 3D E-ALND的中位手术时间为39(IQR = 28,49)分钟。E-ALND期间的平均失血量为3(IQR = 3,5)mL。收获淋巴结的中位数为10(IQR = 8,11)个。在中位随访时间7个月期间,未发现并发症、淋巴水肿、肩部僵硬或慢性手臂麻木。所有患者均未报告局部区域复发、远处转移或死亡。S-P 3D E-ALND可作为接受EABS的乳腺癌患者进行ALND的替代方法,因为我们的研究结果表明其仅导致轻微并发症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31b2/11634405/c91fea845619/TBJ2024-6319218.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31b2/11634405/a3dcf0a7ef6d/TBJ2024-6319218.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31b2/11634405/c91fea845619/TBJ2024-6319218.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31b2/11634405/a3dcf0a7ef6d/TBJ2024-6319218.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/31b2/11634405/c91fea845619/TBJ2024-6319218.002.jpg

相似文献

1
Single-Port Three-Dimensional Endoscopic-Assisted Axillary Lymph Node Dissection (S-P 3D E-ALND): Surgical Technique and Preliminary Results.单孔三维内镜辅助腋窝淋巴结清扫术(S-P 3D E-ALND):手术技术及初步结果
Breast J. 2024 Dec 4;2024:6319218. doi: 10.1155/tbj/6319218. eCollection 2024.
2
Axillary treatment for operable primary breast cancer.可手术原发性乳腺癌的腋窝治疗
Cochrane Database Syst Rev. 2017 Jan 4;1(1):CD004561. doi: 10.1002/14651858.CD004561.pub3.
3
Recommendation for axillary lymph node dissection in women with early breast cancer and sentinel node metastasis: A systematic review and meta-analysis of randomized controlled trials using the GRADE system.早期乳腺癌伴前哨淋巴结转移女性腋窝淋巴结清扫的推荐:使用 GRADE 系统的随机对照试验的系统评价和荟萃分析。
Int J Surg. 2016 Oct;34:73-80. doi: 10.1016/j.ijsu.2016.08.022. Epub 2016 Aug 22.
4
Omission of axillary lymph node dissection in patients with breast cancer with axillary pathological complete response confirmed by stained region lymph node biopsy after neoadjuvant systemic therapy (SrLNB study): study protocol for a single-arm, single-centre, phase-II trial.新辅助全身治疗后经染色区域淋巴结活检证实腋窝病理完全缓解的乳腺癌患者省略腋窝淋巴结清扫术(SrLNB研究):一项单臂、单中心、II期试验的研究方案
BMJ Open. 2025 Mar 31;15(3):e092563. doi: 10.1136/bmjopen-2024-092563.
5
Axillary reverse mapping in N0 patients requiring sentinel lymph node biopsy - A systematic review of the literature and necessity of a randomised study.需要前哨淋巴结活检的N0患者的腋窝反向映射——文献系统评价及随机研究的必要性
Breast. 2017 Jun;33:57-70. doi: 10.1016/j.breast.2017.02.019. Epub 2017 Mar 8.
6
Different strategies in de-escalation of axillary surgery in node-positive breast cancer following neoadjuvant treatment: a systematic review and meta-analysis of long-term outcomes.新辅助治疗后腋窝淋巴结阳性乳腺癌腋窝手术降阶梯治疗的不同策略:长期结局的系统评价和荟萃分析
Breast Cancer. 2025 Apr 5. doi: 10.1007/s12282-025-01692-9.
7
Changing practice patterns in axillary management for patients with node-positive breast cancer towards increased use of sentinel lymph node biopsy-alone after neoadjuvant chemotherapy: results of a survey (MF17-01) among Turkish surgeons.新辅助化疗后,针对淋巴结阳性乳腺癌患者的腋窝处理模式发生变化,更多地采用仅前哨淋巴结活检:一项针对土耳其外科医生的调查(MF17 - 01)结果
Langenbecks Arch Surg. 2025 Jun 16;410(1):196. doi: 10.1007/s00423-025-03767-9.
8
Trends in Surgical Axillary Staging and Clinical Outcomes Among Breast Cancer Patients With Neoadjuvant Therapy: A Population-Based Cohort Study.接受新辅助治疗的乳腺癌患者腋窝手术分期及临床结局的趋势:一项基于人群的队列研究
Clin Breast Cancer. 2025 Jul;25(5):e525-e532.e3. doi: 10.1016/j.clbc.2025.02.001. Epub 2025 Feb 6.
9
Prevention of Seroma Formation and Its Sequelae After Axillary Lymph Node Dissection: An Up-to-Date Systematic Review and Guideline for Surgeons.腋窝淋巴结清扫术后血清肿形成及其后遗症的预防:外科医生的最新系统评价与指南
Ann Surg Oncol. 2024 Mar;31(3):1643-1652. doi: 10.1245/s10434-023-14631-9. Epub 2023 Dec 1.
10
Safety and Accuracy of Sentinel Lymph Node Biopsy Alone in Clinically Node-Positive Patients Undergoing Upfront Surgery for Invasive Breast Cancer: A Systematic Review.单独使用前哨淋巴结活检术在浸润性乳腺癌行 upfront 手术的临床阳性淋巴结患者中的安全性和准确性:一项系统评价。
Curr Oncol. 2023 Mar 7;30(3):3102-3110. doi: 10.3390/curroncol30030235.

本文引用的文献

1
Ribociclib plus Endocrine Therapy in Early Breast Cancer.来曲唑联合内分泌治疗早期乳腺癌。
N Engl J Med. 2024 Mar 21;390(12):1080-1091. doi: 10.1056/NEJMoa2305488.
2
Feasibility analysis of treating breast cancer patients with breast-conserving surgery via a periareolar incision combined with non-lipolytic suspension-type mastoscopy.经乳晕切口联合非脂解型悬吊式乳腔镜行保乳手术治疗乳腺癌的可行性分析。
Sci Rep. 2023 Jul 26;13(1):12129. doi: 10.1038/s41598-023-39199-y.
3
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial.
阿贝西利联合内分泌治疗激素受体阳性、HER2 阴性、淋巴结阳性、高危早期乳腺癌(monarchE):一项随机、开放标签、III 期临床试验的预先计划的中期分析结果。
Lancet Oncol. 2023 Jan;24(1):77-90. doi: 10.1016/S1470-2045(22)00694-5. Epub 2022 Dec 6.
4
Association of Long-term Oncologic Prognosis With Minimal Access Breast Surgery vs Conventional Breast Surgery.微创乳房手术与传统乳房手术对长期肿瘤预后的影响。
JAMA Surg. 2022 Dec 1;157(12):e224711. doi: 10.1001/jamasurg.2022.4711. Epub 2022 Dec 14.
5
17-Year Follow-up of Comparing Mastoscopic and Conventional Axillary Dissection in Breast Cancer: A Multicenter, Randomized Controlled Trial.乳腺癌改良根治术与传统根治术的 17 年随访比较:多中心随机对照研究
Adv Ther. 2022 Jun;39(6):2961-2970. doi: 10.1007/s12325-022-02152-y. Epub 2022 Apr 29.
6
Near-infrared laparoscopy with indocyanine green for axillary sentinel lymph node biopsy in early breast cancer: preliminary experience of a single unit.近红外腹腔镜联合吲哚菁绿用于早期乳腺癌腋窝前哨淋巴结活检:单中心初步经验
Gland Surg. 2021 May;10(5):1677-1686. doi: 10.21037/gs-21-223.
7
Oncologic Outcome of Endoscopic Assisted Breast Surgery Compared with Conventional Approach in Breast Cancer: An Analysis of 3426 Primary Operable Breast Cancer Patients from Single Institute with and Without Propensity Score Matching.内镜辅助保乳手术与传统方法治疗乳腺癌的肿瘤学结局:单中心 3426 例可手术原发性乳腺癌患者的分析,包括倾向评分匹配和未匹配。
Ann Surg Oncol. 2021 Nov;28(12):7368-7380. doi: 10.1245/s10434-021-09950-8. Epub 2021 May 11.
8
Single-Port Three-Dimensional (3D) Videoscope-Assisted Endoscopic Nipple-Sparing Mastectomy in the Management of Breast Cancer: Technique, Clinical Outcomes, Medical Cost, Learning Curve, and Patient-Reported Aesthetic Results from 80 Preliminary Procedures.单孔三维(3D)内窥镜辅助内镜保乳乳腺癌切除术:80 例初步手术的技术、临床结果、医疗费用、学习曲线和患者报告的美容结果。
Ann Surg Oncol. 2021 Nov;28(12):7331-7344. doi: 10.1245/s10434-021-09964-2. Epub 2021 May 1.
9
Oncological safety of selective axillary dissection after axillary reverse mapping in node-positive breast cancer.腋窝反像法指导下腋窝前哨淋巴结活检阳性乳腺癌患者选择性腋窝清扫术的肿瘤安全性。
Eur J Surg Oncol. 2021 Jul;47(7):1606-1610. doi: 10.1016/j.ejso.2020.10.031. Epub 2020 Nov 1.
10
Endoscopic assisted breast conserving surgery for breast cancer: Clinical outcome, learning curve, and patient reported aesthetic results from preliminary 100 procedures.内镜辅助保乳手术治疗乳腺癌:初步 100 例的临床结果、学习曲线和患者报告的美学结果。
Eur J Surg Oncol. 2020 Aug;46(8):1446-1455. doi: 10.1016/j.ejso.2020.02.020. Epub 2020 Feb 20.